<DOC>
	<DOCNO>NCT00002348</DOCNO>
	<brief_summary>To estimate response rate , response duration , clinical benefit , toxicity mitoguazone dihydrochloride ( MGBG ) patient AIDS-related refractory relapse non-Hodgkin 's lymphoma ( NHL ) .</brief_summary>
	<brief_title>A Study Mitoguazone Dihydrochloride Patients With AIDS-Related Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>Patients receive infusion MGBG day 1 8 every 2 week thereafter . It suggest lumbar puncture perform evaluate leptomeningeal disease .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Mitoguazone</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV positivity ELISA confirm Western blot . AIDSrelated NHL refractory relapse . Life expectancy least 12 week . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Concomitant malignancy OTHER THAN curatively treat carcinoma situ cervix ; basal squamous cell carcinoma skin ; nonactive , nonvisceral Kaposi 's sarcoma require active chemotherapy . Active uncontrolled bacterial infection , viral infection ( herpes simplex ) , fungal infection ( oropharyngeal candidiasis ) require treatment within 2 week study entry . Significant cardiovascular disease . Concurrent Medication : Excluded : Hormonal therapy ( except medication give muscle wasting , testosterone Megace ) . Other chemotherapy . Investigational anticancer drug . Concurrent Treatment : Excluded : Concomitant radiation site CNS . Patients follow prior condition exclude : Prior malignancy OTHER THAN curatively treat carcinoma situ cervix ; basal squamous cell carcinoma skin ; nonactive , nonvisceral Kaposi 's sarcoma require active chemotherapy . Recommended : Prophylaxis PCP oral candidiasis . Required patient leptomeningeal disease : Intrathecal methotrexate cytarabine ( AraC ) . Leucovorin . Required patient leptomeningeal disease : Cranial radiation helmet field .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1996</verification_date>
	<keyword>Lymphoma , Non-Hodgkin</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Lymphoma , AIDS-Related</keyword>
	<keyword>Mitoguazone</keyword>
</DOC>